EcoDrugPlus

Ensembl ID : YCL040W
Description: -
77 Possible Orthologues:

Title

Ensembl ID : YCR026C
Description: -
185 Possible Orthologues:

Title

Ensembl ID : YCR031C
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YCR048W
Description: -
63 Possible Orthologues:

Title

Ensembl ID : YCR091W
Description: -
185 Possible Orthologues:

Title

Ensembl ID : YCR102C
Description: -
920 Possible Orthologues:

Title

Ensembl ID : YCR105W
Description: -
917 Possible Orthologues:

Title

Ensembl ID : YCR107W
Description: -
800 Possible Orthologues:

Title

Ensembl ID : YDL007W
Description: -
117 Possible Orthologues:

Title

Ensembl ID : YDL015C
Description: -
86 Possible Orthologues:

Title

Ensembl ID : YDL017W
Description: -
73 Possible Orthologues:

Title

Ensembl ID : YDL028C
Description: -
65 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).